Cardax (Cardax) Inventories, Raw Materials & Components : $0.76 Mil (As of Mar. 2021)

View and export this data going back to 2012. Start your Free Trial

What is Cardax Inventories, Raw Materials & Components?

Cardax's inventories, raw materials & components for the quarter that ended in Mar. 2021 was $0.76 Mil.

Cardax's quarterly raw materials increased from Sep. 2020 ($0.30 Mil) to Dec. 2020 ($0.76 Mil) but then stayed the same from Dec. 2020 ($0.76 Mil) to Mar. 2021 ($0.76 Mil).

Cardax's annual raw materials declined from Dec. 2018 ($1.38 Mil) to Dec. 2019 ($0.76 Mil) and declined from Dec. 2019 ($0.76 Mil) to Dec. 2020 ($0.76 Mil).

Cardax Inventories, Raw Materials & Components Historical Data

The historical data trend for Cardax's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardax Inventories, Raw Materials & Components Chart

Cardax Annual Data

Trend

Mar12

Mar13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Inventories, Raw Materials & Components

Get a 7-Day Free Trial

0.10

1.38

0.76

Cardax Quarterly Data
	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21
Inventories, Raw Materials & Components	Get a 7-Day Free Trial															0.76	0.76	0.30	0.76	0.76

Cardax Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

Cardax (Cardax) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardax Inc (OTCPK:CDXI) » Definitions » Inventories, Raw Materials & Components

Comparable Companies

IMUN BOM:506365 PPCB HSTC XCNQ:NSHS RSPI BOM:542910 BOM:539206 RBSH GNBT

Traded in Other Exchanges

N/A

Address

2800 Woodlawn Drive, Suite 129, Honolulu, HI, USA, 96822

Website

http://www.cardaxpharma.com

Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.

Executives

Paulson Capital Corp	10 percent owner	222 THIRD STREET, SUITE 2241, CAMBRIDGE MA 02142
Paulson Investment Company, Inc.	10 percent owner	5335 MEADOWS ROAD SUITE 465 LAKE OSWEGO OR 97035
Paulson Cardax Investments 1 Llc	10 percent owner	811 SW NAITO PKWY SUITE 300 PORTLAND OR 97204